CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $64,039
- in 7 filings, $7K under 10b5-1 plans
Net −$64,039. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Lee Kevin −$27K CHIEF EXECUTIVE OFFICER sold 1% of stake
- Swanton Robert Charles −$12K Director sold 18% of stake
- Skynner Michael −$9K CHIEF SCIENTIFIC OFFICER sold 2% of stake
- Perry Jennifer Scott −$7K Chief Operating Officer sold 2% of stake
- Hannay Michael Charles Ferguson −$6K CHIEF PROD & SUPPLY CHAIN OFF sold 2% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-19 | Kalowski Lee President and CFO | Option exercise · Stock Option (Right to Buy) | −15,000 | 79,774 | ||
| 2021-01-15 | Lee Kevin Chief Executive Officer | Sale | −5,000 | $27.01 | $135K | 265,085 |
| 2021-01-14 | Kalowski Lee President and CFO | Option exercise | +10,000 | $1.60 | $16K | 10,000 |
| 2021-01-14 | Kalowski Lee President and CFO | Sale | −10,000 | $25.00 | $250K | 0 |
| 2021-01-14 | Kalowski Lee President and CFO | Option exercise · Stock Option (Right to Buy) | −10,000 | 94,774 | ||
| 2021-01-14 | Lee Kevin Chief Executive Officer | Sale | −5,000 | $25.00 | $125K | 270,085 |
| 2021-01-04 | Winter Gregory Paul Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2021-01-04 | Smethurst Dominic Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +27,621 | 27,621 | ||
| 2021-01-04 | Skynner Michael Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +70,500 | 70,500 | ||
| 2021-01-04 | Legault Pierre Director | Grant or award · Stock Option (right to buy) | +38,000 | 38,000 | ||
| 2021-01-04 | Lee Kevin Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2021-01-04 | Kender Richard N Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2021-01-04 | Keen Nicholas Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +70,500 | 70,500 | ||
| 2021-01-04 | Kalowski Lee President and CFO | Grant or award · Employee Stock Option (right to buy) | +70,500 | 70,500 | ||
| 2021-01-04 | Jordan Veronica GH Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2021-01-04 | Crockett Nigel Chief Business Officer | Grant or award · Employee Stock Option (right to buy) | +70,500 | 70,500 | ||
| 2021-01-04 | Bourque Janice Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2021-01-04 | BINGHAM KATE Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2020-12-01 | Kalowski Lee President and CFO | Option exercise | +7,500 | $1.56 | $12K | 7,500 |
| 2020-12-01 | Kalowski Lee President and CFO | Sale | −7,500 | $22.50 | $169K | 0 |
Page 27 of 34 · 664 trades